Livestock biotech focuses on next-generation developments in animal biotechnology to increase the productivity of livestock, making them suitable for agricultural use. Developments in technologies such as gene editing techniques including transcription activator-like effector nucleases (TALENs), zinc finger nucleases (ZFNs), and clustered regularly interspaced short palindromic repeats (CRISPR/Cas9), precision breeding of livestock using genetic engineering, transgenics (genetically modified animals), and genomic testing are used to prevent diseases and develop genetically superior animals. The industry also covers next-generation developments in vaccines and drugs to prevent and treat diseases among livestock as well as animal feed additives developed using biotechnology. 

Despite being highly regulated in the US, these developments in genetic engineering allow livestock producers to “create” breeds with superior traits and better productivity, quality, and consistency faster than conventional selective breeding methods. Advances in molecular biology and genetic engineering (CRISPR/Cas9) have been key enablers for the industry.

Note: Additional sections (such as market sizing, detailed overview, and incumbents) can be provided on request.